Allergy and Immunology · Tulsa, OK
NPI
1861465916
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6160 S Yale Ave
Tulsa, OK, 74136
Phone (918) 495-2636
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
16,142 services
Medicare patients, 2024
428
Average age 72
Drug cost, 2024
$3.5M
2,843 prescriptions
Company payments, 2025
$3,609
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lynn A Wiens was code 95165 (treatment - miscellaneous), 9,007 times for 198 patients. In total Lynn A Wiens billed 16,142 services in 25 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 9,007 | 198 | $9.65 | $87K |
| 95004 Test - Miscellaneous | Office | 3,195 | 53 | $2.41 | $7,697 |
| 95117 Treatment - Miscellaneous | Office | 2,400 | 214 | $7.25 | $17K |
| 95024 Test - Miscellaneous | Office | 381 | 35 | $5.43 | $2,070 |
| 99214 Office E&M - Established | Office | 300 | 224 | $85.55 | $26K |
| 95115 Treatment - Miscellaneous | Office | 218 | 29 | $5.95 | $1,296 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 149 | 132 | $11.19 | $1,667 |
| 96372 Injection Administration | Office | 104 | 17 | $8.56 | $891 |
| 99204 Office E&M - New | Office | 74 | 74 | $108.45 | $8,025 |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 49 | 46 | $0.04 | $1.8 |
| 94060 Pulmonary Function Testing | Office | 48 | 47 | $27.34 | $1,312 |
| 99213 Office E&M - Established | Office | 30 | 30 | $62.00 | $1,860 |
| 99203 Office E&M - New | Office | 14 | 14 | $69.45 | $972 |
By year: 2022 $111K for 11,288 services; 2023 $177K for 16,958 services; 2024 $159K for 16,142 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lynn A Wiens prescribed most often to Medicare patients was Montelukast Sodium, with 284 prescriptions and refills. In total Lynn A Wiens wrote 2,843 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 284 | 691 | 83 | $6,761 |
| Ipratropium Bromide Generic | 256 | 332 | 89 | $6,273 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 178 | 210 | 30 | $130K |
| Azelastine Hcl Generic | 142 | 209 | 49 | $3,544 |
| Fluticasone Propionate Generic | 134 | 221 | 46 | $2,652 |
| Pantoprazole Sodium Generic | 121 | 248 | 44 | $2,056 |
| Xolair Omalizumab | 117 | 117 | 13 | $326K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 109 | 147 | 47 | $2,907 |
| Levocetirizine Dihydrochloride Generic | 96 | 216 | 31 | $2,421 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 83 | 86 | 21 | $51K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 75 | 94 | 21 | $8,146 |
| Omeprazole Generic | 73 | 147 | 24 | $1,286 |
| Famotidine Generic | 57 | 105 | 20 | $787 |
| Dupixent Pen Dupilumab | 52 | 59 | 12 | $235K |
| Epinephrine Generic | 49 | 51 | 43 | $8,409 |
Brand drugs: 980 claims; generic drugs: 1,863 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lynn A Wiens $3,609 ($3,609 in general payments such as food, travel and fees) from 22 companies. The largest payer was Genzyme Corporation with $687.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 25 | $687 |
| Pfizer Inc. PFE | 25 | $399 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 12 | $313 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $285 |
| Pharming Healthcare, Inc. | 10 | $239 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $234 |
| CSL Behring CSL.AX | 11 | $207 |
| GlaxoSmithKline, LLC. GSK | 15 | $190 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $168 |
| Genentech USA, Inc. ROG.SW | 7 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.